EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Nebulization versus metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study

Rongli Lu, Ying Li, Chengping Hu, Pinhua Pan iD, Qiaohong Zhao, Ruoxi He iD

Therapeutic Advances in Respiratory Disease · 2023

DOI: 10.1177/17534666231214134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2023. Verfasst von Rongli Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hos…. Hauptthemen laut MEDLINE: Bronchodilator Agents, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The recommended delivery mode for bronchodilators in bronchodilator responsiveness (BDR) testing remains controversial.

Objective

To compare the efficacy of salbutamol administration using a nebulizer versus a metered-dose inhaler (MDI) with spacer in BDR testing.

Design

A retrospective study.

Methods

This study examined the data of patients with chronic obstructive pulmonary disease who completed BDR testing between 1 December 2021 and 30 June 2022, at Xiangya Hospital, Central South University. After administering 400 μg of salbutamol through an MDI with spacer or 2.5 mg using a nebulizer, the changes in forced expiratory volume in one second (FEV 1 ) and forced vital capacity (FVC) were analyzed in patients with moderate-to-very severe spirometric abnormalities [pre-bronchodilator FEV 1 percentage predicted values (FEV 1 %pred) ⩽59%]. Significant responsiveness was assessed as >12% and >200 mL improvement in FEV 1 and/or FVC or >10% increase in FEV 1 %pred or FVC percentage predicted values (FVC%pred) from pre- to post-bronchodilator administration.

Results

Of the enrolled 894 patients, 83.2% were male (median age, 63 years). After propensity score matching, 240 pairs of patients were selected. The increment in FEV 1 and increased FEV 1 relative to the predicted value (ΔFEV 1 %pred) were significantly higher in patients 12% and >200 mL increase criterion, the significant BDR rate with nebulization was 1.67 times higher than that with an MDI with spacer (OR = 1.67, 95% CI: 1.13–2.47, p = 0.009).

Conclusion

Salbutamol delivered using a nebulizer may be preferable to an MDI with spacer in certain circumstances. Nebulization has the potential to increase responsiveness to salbutamol in BDR testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchodilator AgentsPulmonary Disease, Chronic ObstructiveHumansMaleMiddle AgedFemaleRetrospective StudiesNebulizers and VaporizersAdministration, InhalationAlbuterolForced Expiratory Volume

Stichwörter der Autor:innen

bronchodilator responsivenesschronic obstructive pulmonary diseasemetered-dose inhalernebulizationsalbutamolspirometry

Substanzen

Bronchodilator AgentsAlbuterol

Autor:innen und Institutionen

  • Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Hunan, China.
  • Center of Respiratory Medicine, Xiangya Hospital, Central South University, Hunan, China.
  • Clinical Research Center for Respiratory Diseases in Hunan Province, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan, China.
  • Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, 87th Xiangya Road, Changsha, Hunan 41…
  • Clinical Research Center for Respiratory Diseases in Hunan Province, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan, China.

ORCID-Profile: Pinhua Pan, Ruoxi He

Förderung

  • Natural Science Foundation of Hunan Province

Zitieren

APA

Lu, R., Li, Y., Hu, C., Pan, P., Zhao, Q., & He, R. (2023). Nebulization versus metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666231214134

Vancouver

Lu R, Li Y, Hu C, Pan P, Zhao Q, He R. Nebulization versus metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study. Therapeutic Advances in Respiratory Disease. 2023. doi:10.1177/17534666231214134

BibTeX
@article{Lu2023,
  author = {Lu, Rongli and Li, Ying and Hu, Chengping and Pan, Pinhua and Zhao, Qiaohong and He, Ruoxi},
  title = {Nebulization versus metered-dose inhaler and spacer in bronchodilator responsiveness testing: a retrospective study},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2023},
  doi = {10.1177/17534666231214134}
}
Kostenlos starten →